Jazz Pharmaceuticals plc

NASDAQ:JAZZ

109.565 (USD) • At close September 18, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Omzet 3,834.2043,659.3743,094.2382,363.5672,161.7611,890.9221,618.6931,487.9731,324.8031,172.875872.423585.979272.277173.781128.44967.51465.30344.85621.4420
Kosten van de omzet 1,043.861540.517440.76148.917127.93121.544110.188105.386102.526117.418102.14678.42513.94213.5599.63813.9248.9036.9684.2920
Brutowinst 2,790.3433,118.8572,653.4782,214.652,033.8311,769.3781,508.5051,382.5871,222.2771,055.457770.277507.554258.335160.222118.81153.5956.437.88817.150
Brutowinstmarge 0.7280.8520.8580.9370.9410.9360.9320.9290.9230.90.8830.8660.9490.9220.9250.7940.8640.8450.80
Onderzoek- en ontwikkelingskosten 849.658590.453505.748335.375299.726226.616198.442162.297135.25385.18146.6220.47714.1225.61236.56169.96369.79254.95645.7830
Algemene en administratieve kosten 000000000380.414303.303223.18200000000
Verkoop- en marketingkosten 00000000025.710.700000000
Verkoop-, algemene en administratieve kosten 1,281.4051,416.9671,451.683854.233736.942683.53544.156502.892449.119406.114304.303223.882108.93668.99658.652111.40178.5451.38423.5510
Overige kosten 1,476.942599.169525.769259.58354.814201.498152.065101.99498.162126.58479.04265.3517.4487.8257.66812.82846.8469.64.96-24.804
Bedrijfskosten 2,131.0632,606.5892,483.21,449.1881,391.4821,111.644894.663767.183682.534617.879429.965309.71130.504102.433102.881194.192195.178115.9474.294-24.804
Bedrijfsresultaat 659.28512.268170.278765.462532.374614.838528.842591.654508.22195.587340.312197.844127.83157.78915.93-170.365-138.778-78.052-78.444-24.804
Bedrijfsresultaat ratio 0.1720.140.0550.3240.2460.3250.3270.3980.3840.1670.390.3380.4690.3330.124-2.523-2.125-1.74-3.6580
Totaal overige inkomsten en kosten netto -361.351-885.052-283.116-490.367-78.072-51.196-94.969-21.016-46.893-233.308-5.446-3.62-1.247-12.289-0.004-25.829-29.97230.483-22.2010
Inkomen voor belasting 297.929-372.784-112.838275.095454.302529.463441.117532.446435.933151.557307.95177.355124.98432.778-6.836-184.339-138.826-47.569-100.6450
Inkomen voor belasting ratio 0.078-0.102-0.0360.1160.210.280.2730.3580.3290.1290.3530.3030.4590.189-0.053-2.73-2.126-1.06-4.6940
Belastingkosten -119.912-158.645216.11633.517-73.15480.162-47.74135.236106.39994.23191.638-83.7942.84725.01122.76643.7370.048-18.66128.01224.804
Nettowinst 414.832-214.139-328.954238.616523.367447.098487.848396.831329.53558.387216.312288.586124.98432.778-6.836-184.339-138.826-59.391-85.156-24.804
Nettowinstmarge 0.108-0.059-0.1060.1010.2420.2360.3010.2670.2490.050.2480.4920.4590.189-0.053-2.73-2.126-1.324-3.9710
WPA (Winst Per Aandeel) 6.55-3.42-5.514.289.227.458.136.565.380.983.715.093.010.9-0.23-7.19-10.04-4.41-6.32-1.84
Verwaterde WPA 6.1-3.42-5.514.229.097.37.966.415.230.933.514.792.670.83-0.23-7.19-10.04-4.41-6.32-1.84
EBITDA 1,297.9761,111.437696.0471,025.042997.163859.232765.907717.398637.905564.162422.402272.073136.90577.90323.602-99.747-98.28-98.225-29.504-24.804
EBITDA ratio 0.3390.3040.2250.4340.4610.4540.4730.4820.4820.4810.4840.4640.5030.4480.184-1.477-1.505-2.19-1.3760